Trans-scleral drug delivery method and apparatus
First Claim
1. A method of treating ocular disorders involving angiogenesis, comprising the steps of:
- providing a trans-scleral drug delivery device comprising;
an insert stabilizer for attachment to a scleral surface and having an interlock opening;
a replaceable implant having a reservoir adjacent the scleral surface and an interlock tab, wherein said insert stabilizer and said replaceable implant are removeably connectable by mating said interlock tab and said interlock opening;
providing an anti-angiogenic factor;
introducing said anti-angiogenic factor into said reservoir; and
attaching said insert stabilizer to the scleral surface.
1 Assignment
0 Petitions
Accused Products
Abstract
A method of treating ocular disorders involving angiogenesis includes the steps of providing a trans-scleral drug delivery device comprising an insert stabilizer for attachment to a scleral surface and having an interlock opening and a replaceable implant having a reservoir adjacent the scleral surface and an interlock tab, wherein said insert stabilizer and said replaceable implant are removeably connectable by mating said interlock tab and said interlock opening; providing an anti-angiogenic factor; introducing said anti-angiogenic factor into said reservoir; and attaching said insert stabilizer to the scleral surface. The reservoir can be refilled by disengaging the implant from the stabilizer, inserting a new dosage of anti-angiogenic factor, and reconnecting the implant to the stabilizer or injecting a new dosage of anti-angiogenic factor into the reservoir through an injection port in the stabilizer.
24 Citations
21 Claims
-
1. A method of treating ocular disorders involving angiogenesis, comprising the steps of:
-
providing a trans-scleral drug delivery device comprising;
an insert stabilizer for attachment to a scleral surface and having an interlock opening;
a replaceable implant having a reservoir adjacent the scleral surface and an interlock tab, wherein said insert stabilizer and said replaceable implant are removeably connectable by mating said interlock tab and said interlock opening;
providing an anti-angiogenic factor;
introducing said anti-angiogenic factor into said reservoir; and
attaching said insert stabilizer to the scleral surface. - View Dependent Claims (2, 3, 4, 5, 6, 7)
-
-
8. A method of treating ocular disorders involving angiogenesis, comprising the steps of:
-
providing a two-piece, interlocking, trans-scleral delivery device having a first piece attached to a scleral surface and a second piece having a reservoir; and
administering an anti-angiogenic factor in pellet form to the scleral surface via the reservoir of the trans-scleral delivery device. - View Dependent Claims (9, 10, 11)
-
-
12. A method of treating ocular disorders involving angiogenesis, comprising the steps of:
-
providing a trans-scleral drug delivery device comprising;
an insert stabilizer for attachment to a scleral surface and having an interlock opening and an injection port;
a replaceable implant having a reservoir adjacent the scleral surface and an interlock tab, wherein said insert stabilizer and said replaceable implant are removeably connectable by mating said interlock tab and said interlock opening and wherein said injection port communicates with said reservoir;
providing an anti-angiogenic factor;
introducing said anti-angiogenic factor into said reservoir;
attaching said insert stabilizer to the scleral surface; and
refilling said trans-scleral drug delivery device alternately and selectively by disengaging said replaceable implant from said insert stabilizer, placing a new dosage of angiogenic factor in a pellet form in said reservoir, and re-interlocking said replaceable implant with said insert stabilizer, and injecting a new dosage of angiogenic factor in liquid form in said reservoir through the injection port. - View Dependent Claims (13)
-
-
14. A method of treating ocular disorders involving angiogenesis, comprising the steps of:
-
providing a trans-scleral drug delivery device comprising;
an insert stabilizer for attachment to a scleral surface and having an interlock opening;
a replaceable implant having a reservoir adjacent the scleral surface and an interlock tab;
interlocking said insert stabilizer and said replaceable implant by connecting said interlock tab and said interlock opening;
providing a pellet of carboxyamido-triazole; and
placing said pellet in said reservoir;
attaching said insert stabilizer to the scleral surface; and
refilling said trans-scleral drug delivery device by disengaging said replaceable implant from said insert stabilizer, placing a second pellet of carboxyamido-triazole in said reservoir, and re-interlocking said replaceable implant with said insert stabilizer.
-
-
15. An ophthalmic, trans-scleral drug delivery device, comprising:
-
an insert stabilizer for attachment to a scleral surface and having an interlock opening;
a replaceable implant having a reservoir adjacent the scleral surface and an interlock tab; and
wherein said insert stabilizer and said replaceable implant are removeably engaged by connecting the interlock opening and interlock tab. - View Dependent Claims (16, 17, 18, 19, 20)
-
-
21. The use of carboxyamido-triazole for trans-scleral administration to a human patient experiencing ocular angiogenesis.
Specification